In an adolescent, can a lymph node biopsy differentiate between Kawasaki disease and multisystem inflammatory syndrome in children (MIS‑C)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 22, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Lymph Node Biopsy Cannot Differentiate Between Kawasaki Disease and MIS-C

Lymph node biopsy is not useful for distinguishing between Kawasaki disease (KD) and multisystem inflammatory syndrome in children (MIS-C), as lymph node pathology in KD is nonspecific and nondiagnostic 1. The differentiation between these conditions relies instead on clinical features, epidemiology, laboratory markers, and cardiac findings.

Why Lymph Node Biopsy Is Not Helpful

The 2017 American Heart Association guidelines explicitly state that lymph node pathology in Kawasaki disease is nonspecific and nondiagnostic 1. While cervical lymphadenopathy is a recognized clinical feature shared by both KD and MIS-C 2, the histopathologic findings do not provide distinguishing characteristics between these conditions or other inflammatory processes.

How to Actually Differentiate KD from MIS-C

Since lymph node biopsy won't help, use this algorithmic approach:

Age and Demographics

  • MIS-C: Broader age range, typically older children and adolescents (median ~7 years) 3, 4
  • KD: Primarily children under 5 years (median ~2 years) 3
  • MIS-C: More common in African, Afro-Caribbean, and Hispanic descent; less common in East Asian descent 2

Clinical Presentation

  • Gastrointestinal symptoms: Much more prominent in MIS-C (84% vs 31% in KD) 3
  • Shock and cardiac dysfunction: More frequent in MIS-C (33% ICU admission vs 7.5% in KD) 3
  • Neurologic symptoms: More prominent in MIS-C 2
  • Classic KD features (conjunctivitis, oral changes, rash, extremity changes): More complete in KD 3, 4
  • BCG vaccination site reactivation: More specific for KD 4

Laboratory Markers at Presentation

Higher in MIS-C:

  • Procalcitonin (>1.62 ng/mL is a risk factor for hemodynamic compromise) 4
  • Ferritin (mean 370 ng/mL) 3
  • CRP levels (generally higher than KD) 2

Higher in KD:

  • Platelet count (median 390 vs 236 × 10³/µL) 3
  • Absolute lymphocyte count (mean 3.92 vs 2.59 × 10³/µL) 3
  • ESR (mean 73 vs 51 mm/hr) 3
  • White blood cell count (mean 16.30 vs 11.56 × 10³/µL) 3

Cardiac Findings

  • Mitral regurgitation: Significantly more common in MIS-C and serves as a potential diagnostic hallmark 5
  • Ventricular dysfunction and arrhythmias: More frequent in MIS-C 2
  • Pericarditis and congestive heart failure: More common in MIS-C 5

SARS-CoV-2 Testing

  • Essential step: MIS-C requires evidence of recent SARS-CoV-2 infection (PCR or serology) 2
  • Consider community prevalence when interpreting results 2

Clinical Pitfalls to Avoid

  1. Don't rely on single features: Both conditions share overlapping mucocutaneous manifestations 2, 6
  2. Don't delay treatment for biopsy: Both conditions require prompt immunomodulatory therapy to prevent cardiac complications
  3. Don't dismiss incomplete presentations: Younger MIS-C patients may present with more KD-like features, while older children develop more shock and myocarditis 2
  4. Don't forget multidisciplinary consultation: Both conditions require involvement of pediatric rheumatology, cardiology, infectious disease, and hematology 2

Practical Diagnostic Approach

In an adolescent with fever and inflammatory features:

  1. Check SARS-CoV-2 status (PCR and serology)
  2. Assess for shock/cardiac dysfunction (vital signs, troponin, BNP, echocardiogram with attention to mitral valve)
  3. Evaluate GI symptoms (abdominal pain, vomiting, diarrhea)
  4. Obtain key labs: Procalcitonin, ferritin, CRP, CBC with differential, ESR
  5. Look for classic KD features: conjunctivitis, oral changes, rash, extremity changes, BCG site changes
  6. Perform echocardiogram: Evaluate for mitral regurgitation, ventricular function, coronary arteries

The presence of positive SARS-CoV-2 testing, older age, prominent GI symptoms, shock, mitral regurgitation, elevated procalcitonin/ferritin, and lower platelet counts strongly favor MIS-C over classic KD 3, 4, 5.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.